INS and diabetes mellitus: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of injective anti-diabetes agents that lower blood glucose levels, enhancing insulin secretion in response to nutrient ingestion, without risk of hypoglycemia.